Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma

American Lung Association Epidemiology and Statistics Unit. Trends in asthma morbidity and mortality. Available at: http://www.lungusa.org. Accessed July 2011. Beasley, 2002, The burden of asthma with specific reference to the United States, J Allergy Clin Immunol, 109, S482, 10.1067/mai.2002.122716 2009 Cisternas, 2003, A comprehensive study of the direct and indirect costs of asthma, J Allergy Clin Immunol, 111, 1212, 10.1067/mai.2003.1449 Colice, 2006, Healthcare and workloss costs associated with persistent asthma in a privately insured population, J Occup Environ Med, 48, 794, 10.1097/01.jom.0000229819.26852.0e Godard, 2002, Costs of asthma are correlated with severity, Eur Respir J, 19, 61, 10.1183/09031936.02.00232001 Serra-Battles, 1998, Costs of asthma according to the degree of severity, Eur Respir J, 12, 1322, 10.1183/09031936.98.12061322 Birnbaum, 2009, Asthma severity categorization using a claims-based algorithm or pulmonary function testing, J Asthma, 46, 67, 10.1080/02770900802503099 Sullivan, 2007, Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma, Allergy, 62, 126, 10.1111/j.1398-9995.2006.01254.x Colice, 2008, Costs and resource use of mild persistent asthma patients initiated on controller therapy, J Asthma, 45, 1, 10.1080/02770900801911178 Moore, 2010, Update in asthma 2009, Am J Respir Crit Care Med, 181, 1181, 10.1164/rccm.201003-0321UP 2004 Berger, 2004, The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes, Ann Allergy Asthma Immunol, 93, 538, 10.1016/S1081-1206(10)61260-4 Gelfand, 2006, Use of the Health Plan Employer Data and Information Set for measuring and improving the quality of asthma care, Ann Allergy Asthma Immunol, 97, 298, 10.1016/S1081-1206(10)60793-4 Cabana, 2004, Limits of the HEDIS criteria in determining asthma severity for children, Pediatrics, 114, 1049, 10.1542/peds.2003-1162-L Mosen, 2005, How well do the HEDIS asthma inclusion criteria identify persistent asthma?, Am J Manag Care, 11, 650 Leidy, 1999, Development of an algorithm for estimating asthma severity from an administrative cost database, Value Health, 2, 394, 10.1016/S1098-3015(10)75867-8 Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Update 2010. Available at: http://www.ginasthma.org/pdf/GINA_Report_2010.pdf. Accessed December 23, 2011. Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 Romano, 1993, Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives, J Clin Epidemiol, 46, 1075, 10.1016/0895-4356(93)90103-8 Szefler, 2011, Economic burden of impairment in children with severe or difficult-to-treat asthma, Ann Allergy Asthma Immunol, 107, 110, 10.1016/j.anai.2011.04.008 Birnbaum, 2002, Direct and indirect costs of asthma to an employer, J Allergy Clin Immunol, 109, 264, 10.1067/mai.2002.121310 van Manen, 2001, Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40, Clin Epidemiol, 54, 287, 10.1016/S0895-4356(01)00346-8 Soriano, 2005, Patterns of comorbidities in newly diagnosed COPD and asthma in primary care, Chest, 128, 2099, 10.1378/chest.128.4.2099 Adams, 2006, Coexistent chronic conditions and asthma quality of life: a population-based study, Chest, 129, 285, 10.1378/chest.129.2.285 Gershon, 2010, Burden of comorbidity in individuals with asthma, Thorax, 65, 612, 10.1136/thx.2009.131078 Prosser, 2010, The comorbidity burden of the treated asthma patient population in British Columbia, Chronic Dis Can, 30, 46, 10.24095/hpcdp.30.2.03 2000, Proceedings of the ATS workshop on refractory asthma, Am J Respir Crit Care Med, 162, 2341, 10.1164/ajrccm.162.6.ats9-00 Moore, 2007, Characterization of the severe asthma phenotype by the National Heart, Lung and Blood Institute’s Severe Asthma Research Program, J Allergy Clin Immunol, 119, 405, 10.1016/j.jaci.2006.11.639 2003, The ENFUMOSA cross-sectional European mulicentre study of the clinical phenotype of chronic severe asthma, Eur Respir J, 22, 470, 10.1183/09031936.03.00261903 Gaga, 2005, Risk factors and characteristics associated with severe and difficult to treat asthma phenotype, Clin Exp Allergy, 35, 954, 10.1111/j.1365-2222.2005.02281.x Lee, 2007, Risk factors associated with persistent airflow limitation in severe of difficult-to-treat asthma, Chest, 132, 1882, 10.1378/chest.07-0713 Heaney, 2010, Refractory astuma in the UK, Thorax, 65, 787, 10.1136/thx.2010.137414 Sorkness, 2008, Lung function in adults with stable but severe asthma, J Appl Physiol, 104, 394, 10.1152/japplphysiol.00329.2007 in’t Veen, 2000, Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes, Am J Respir Crit Care Med, 161, 1902, 10.1164/ajrccm.161.6.9906075 Adams, 2002, Inadequate use of asthma medications in the United States, J Allergy Clin Immunol, 110, 58, 10.1067/mai.2002.125489 Kandane-Rathnayake, 2009, Adherence to asthma management guidelines by middle-aged adults with current asthma, Thorax, 64, 1025, 10.1136/thx.2009.118430 Gamble, 2009, The prevalence of nonadherence in difficult asthma, Am J Respir Crit Care Med, 189, 817, 10.1164/rccm.200902-0166OC Williams, 2004, Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma, J Allergy Clin Immunol, 114, 1288, 10.1016/j.jaci.2004.09.028 Yong, 2009, Process quality measures and asthma exacerbations in the Medicaid population, J Allergy Clin Immunol, 124, 961, 10.1016/j.jaci.2009.07.027 Schatz, 2006, The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes, Chest 2006, 130, 43 Schatz, 2005, Asthma quality-of-care markers using administrative data, Chest, 128, 1968, 10.1378/chest.128.4.1968 Thomas, 2003, Database studies in asthma pharmacoeconomics, Expert Opin Pharmocother, 4, 351, 10.1517/14656566.4.3.351